The following is a summary of “Epidermal spongiotic Langerhans cell collections, but not eosinophils, are a clue to the ...

Emphysema did not significantly affect the response to systemic therapy in patients with severe asthma, according to a recent retrospective study. Early improvement was linked to lower baseline FEV1 ...

Detailed results of the ACESO Phase II study published in the peer-reviewed medical journal Alimentary Pharmacology & ...

Asthma affects more than 260M people worldwide and nearly 28M people in the U.S. alone, where, on average, 10 people die from attacks of the chronic disease each day.

This subtype predominantly affects younger individuals. Eosinophils, a type of white blood cell, contribute significantly to ...

In recent weeks there has been a buzz around a new treatment breakthrough: benralizumab, which in a study published in the ...

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following promising clinical trial data.

However, the prognostic potential of β2-MG and eosinophils should be further explored through pivotal prospective trials, given that our current findings stem from a retrospective analysis primarily ...

Allergic diseases represent a group of immune mediated disorders mainly attributed but not limited to IgE, Th2 cytokines and certain cell subsets. Breakthroughs in identifying new biomarkers, novel ...